Changed date for Biovitrum's year-end report 2008

The Biovitrum AB (publ) 2008 year-end report reporting date has been
changed. The report will be published Tuesday February 10, 2009.




About Biovitrum
Biovitrum is a Swedish pharmaceutical company. The company markets  a
range  of  specialist  pharmaceuticals  internationally.  Using   its
expertise and experience  Biovitrum takes  scientific innovation  all
the way  to the  market and  to specialist  indication patients  with
significant medical  need. Research  expertise and  capabilities  are
focused on development and production of biotechnology  therapeutics.
The company has revenues of approximately SEK 1.3 billion and  around
500 employees. It is listed on the OMX Nordic Exchange in  Stockholm.
For more information go to www.biovitrum.com.


For further information, please contact

Göran Arvidson, CFO
Cell phone: +46 70 633 30 42

Erik Kinnman, VP Investor Relations
Cell phone: +46 73 422 15 40
erik.kinnman@biovitrum.com